| Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA S Patel, N Ashwanikumar, E Robinson, A DuRoss, C Sun, ... Nano letters 17 (9), 5711-5718, 2017 | 202 | 2017 |
| Integrating nanomedicine into clinical radiotherapy regimens AN DuRoss, MJ Neufeld, S Rana, CR Thomas Jr, C Sun Advanced drug delivery reviews 144, 35-56, 2019 | 38 | 2019 |
| Fucoidan-coated nanoparticles target radiation-induced P-selectin to enhance chemoradiotherapy in murine colorectal cancer AN DuRoss, MR Landry, CR Thomas Jr, MJ Neufeld, C Sun Cancer letters 500, 208-219, 2021 | 37 | 2021 |
| PEG-lipid micelles enable cholesterol efflux in Niemann-Pick Type C1 disease-based lysosomal storage disorder A Brown, S Patel, C Ward, A Lorenz, M Ortiz, A DuRoss, F Wieghardt, ... Scientific reports 6 (1), 31750, 2016 | 37 | 2016 |
| Biodistribution and toxicity of micellar platinum nanoparticles in mice via intravenous administration AL Brown, MP Kai, AN DuRoss, G Sahay, C Sun Nanomaterials 8 (6), 410, 2018 | 35 | 2018 |
| Inverse-micelle synthesis of doxorubicin-loaded alginate/chitosan nanoparticles and in vitro assessment of breast cancer cytotoxicity JG Rosch, H Winter, AN DuRoss, G Sahay, C Sun Colloid and interface science communications 28, 69-74, 2019 | 30 | 2019 |
| Low dose novel PARP-PI3K inhibition via nanoformulation improves colorectal cancer immunoradiotherapy MR Landry, AN DuRoss, MJ Neufeld, L Hahn, G Sahay, R Luxenhofer, ... Materials Today Bio 8, 100082, 2020 | 22 | 2020 |
| Co-delivery of PARP and PI3K inhibitors by nanoscale metal–organic frameworks for enhanced tumor chemoradiation MJ Neufeld, AN DuRoss, MR Landry, H Winter, AM Goforth, C Sun Nano Research 12, 3003-3017, 2019 | 22 | 2019 |
| Micellar formulation of talazoparib and buparlisib for enhanced DNA damage in breast cancer chemoradiotherapy AN DuRoss, MJ Neufeld, MR Landry, JG Rosch, CT Eaton, G Sahay, ... ACS applied materials & interfaces 11 (13), 12342-12356, 2019 | 21 | 2019 |
| Nanoalginates via inverse-micelle synthesis: doxorubicin-encapsulation and breast cancer cytotoxicity JG Rosch, AL Brown, AN DuRoss, EL DuRoss, G Sahay, C Sun Nanoscale Research Letters 13, 1-10, 2018 | 16 | 2018 |
| PEGylated β-NaGdF4/Tb@CaF2 Core/Shell Nanophosphors for Enhanced Radioluminescence and Folate Receptor Targeting Y Ren, H Winter, JG Rosch, K Jung, AN Duross, MR Landry, G Pratx, ... ACS Applied Nano Materials 2 (6), 3718-3727, 2019 | 13 | 2019 |
| Formulation of folate-modified raltitrexed-loaded nanoparticles for colorectal cancer theranostics JG Rosch, AN DuRoss, MR Landry, C Sun Pharmaceutics 12 (2), 133, 2020 | 7 | 2020 |
| Radiotherapy reimagined: Integrating nanomedicines into radiotherapy clinical trials AN DuRoss, J Phan, AJ Lazar, JM Walker, AR Guimaraes, C Baas, ... Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 15 (3 …, 2023 | 5 | 2023 |
| Preclinical data on co-delivery of temozolomide and talazoparib by fucodain-coated nanoscale metal organic frameworks for colorectal cancer chemoradiation AN DuRoss, MR Landry, CR Thomas Jr, MJ Neufeld, C Sun Data in Brief 38, 107394, 2021 | 4 | 2021 |
| Development of a pemetrexed/folic acid nanoformulation: synthesis, characterization, and efficacy in a murine colorectal cancer model JG Rosch, AN DuRoss, MR Landry, C Sun ACS omega 5 (25), 15424-15432, 2020 | 4 | 2020 |
| Development of a G2/M arrest high-throughput screening method identifies potent radiosensitizers M Landry, D Nelson, E Choi, A DuRoss, C Sun Translational Oncology 16, 101336, 2022 | 3 | 2022 |
| Nanoscale metal-organic frameworks for enhanced tumor chemoradiation CGC Sun, MJ Neufeld, AN DuRoss US Patent App. 17/072,895, 2021 | 2 | 2021 |
| Abstract PO-087: Novel high-throughput screen in a breast cancer cell line to identify potent radiosensitizers MR Landry, AN DuRoss, E Choi, A Jozic, D Nelson, C Sun Clinical Cancer Research 27 (8_Supplement), PO-087-PO-087, 2021 | | 2021 |
| Investigating Multimodal Therapies with Nanotechnology to Engineer Advanced Chemoradiation Platforms AN DuRoss | | 2020 |
| Metal-organic frameworks for radiation-based cancer therapies M Neufeld, AN DuRoss, MR Landry, H Winter, S Khan, ... American Chemical Society SciMeetings 1 (1), 2020 | | 2020 |
Conroy SunAssociate Professor, Oregon State University, College of PharmacyDirección de correo verificada de oregonstate.edu
